NKT cells mediate organ-specific resistance against Leishmania major infection

Microbes and Infection

Volumn 8, Issue 2, 2006, Pages 354-362

  Mattner, Jochen ^a,b   Donhauser, Norbert ^a   Werner Felmayer, Gabriele ^c   Bogdan, Christian ^a,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Innate immunity; Leishmania major; Natural killer T (NKT) cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HOST RESISTANCE; IN VITRO STUDY; INNATE IMMUNITY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DEFECT; SPLEEN; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD1; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGAN SPECIFICITY; SKIN; SPLEEN;

ANIMALIA; LEISHMANIA MAJOR;

EID: 32244438524     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.07.002     Document Type: Article

References (49)

1. C. Bogdan, A. Gessner, and M. Roellinghoff Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions Immunobiology 189 1993 356 396
2. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1199
3. D. Sacks, and N. Noben-Trauth The immunology of susceptibility and resistance to leishmania major in mice Nat. Rev. Immunol. 2 2002 845 858
4. M. Blos, U. Schleicher, F.J. Soares Rocha, U. Meissner, M. Rollinghoff, and C. Bogdan Organ specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase Eur. J. Immunol. 33 2003 1224 1234
5. U. Ritter, J. Mattner, J.S. Rocha, C. Bogdan, and H. Koerner The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain Microbes Infect. 6 2004 559 565
6. C. Bogdan, and M. Roellinghoff The immune response to Leishmania: mechanisms of parasite control and evasion Int. J. Parasitol. 28 1998 121 134
7. W. Solbach, and T. Laskay The host response to Leishmania infection Adv. Immunol. 74 2000 275 317
8. H. Ishikawa, H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, M. Takashima, and K. Himeno CD4 (+) v(alpha) 14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major Int. Immunol. 12 2000 1267 1274
9. J.L. Amphrey, J.S. Im, S.J. Turco, H.W. Murray, P.A. Illarionov, G.S. Besra, S.A. Porcelli, and G.F. Spath A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan J. Exp. Med. 4 2004 895 904
10. S.H. Park, A. Weiss, K. Benlagha, T. Kyin, L. Teyton, and A. Bendelac The mouse CD1d - restricted repertoire is dominated by a few autoreactive T cell receptor families J. Exp. Med. 193 2001 893 904
11. M.K. Slifka, R.R. Pagarigan, and J.L. Whitton NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells J. Immunol. 164 2000 2620 2627
12. T. Yoshimoto, and W.E. Paul CD4 pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 J. Exp. Med. 179 1994 1285 1295
13. J. Cui, T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi Requirement for Valpha NKT cells in IL-12-mediated rejection of tumors Science 278 1997 1623 1626
14. C. Carnaud, D. Lee, O. Donnars, S.H. Park, A. Beavis, Y. Koezuka, and A. Bendelac Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J. Immunol. 163 1999 4647 4650
15. G. Gonzalez-Aseguinolaza, L. Van Kaer, C.C. Bergmann, J.M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines J. Exp. Med. 195 2002 617 624
16. S. Fujii, K. Shimizu, C. Smith, L. Bonifaz, and R.M. Steinman Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein J. Exp. Med. 198 2003 267 279
17. J.E. Gumperz, C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S.A. Porcelli, S. Cardell, M.B. Brenner, and S.M. Behar Murine CD1d-restricted T cell recognition of cellular lipids Immunity 12 2000 211 221
18. D.O. Procopio, I.C. Almeida, A.C. Torrecilhas, J.E. Cardoso, L. Teyton, L.R. Travassos, A. Bendelac, and R.T. Gazzinelli Glycosylphosphatidylinositol- anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway J. Immunol. 169 2002 3926 3933
19. D.Y. Wu, N.H. Segal, S. Sidobre, M. Kronenberg, and P.B. Chapman Cross-presentation of disialoganglioside GD3 to natural killer T cells J. Exp. Med. 198 2003 173 181
20. K. Fischer, E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S.H. Kaufmann, and U.E. Schaible Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells Proc. Natl. Acad. Sci. USA 101 2004 10685 10690
21. D. Zhou, J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. Wu, T. Yamashita, S. Teneberg, D. Wang, R. Proia, S.B. Levery, P.B. Savage, L. Teyton, and A. Bendelac Lysosomal glycosphingolipid recognition by NKT cells Science 306 2004 1786 1789
22. J. Mattner, K.L. DeBord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, K. Hoebe, O. Schneewind, D. Walker, B. Beutler, L. Teyton, P.B. Savage, and A. Bendelac Both exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections Nature 434 2005 525 529
23. Y. Vanloubbeeck, and D.E. Jones The Immunology of Leishmania infection and the implications for vaccine development Ann. N. Y. Acad. Sci. 1026 2004 267 272
24. M. Brigl, L. Bry, S.C. Kent, J.E. Gumperz, and M.B. Brenner Mechanism of CD1d-restricted natural killer T cell activation during microbial infection Nat. Immunol. 12 2003 1230 1237
25. E.E. Nieuwenhuis, T. Matsumoto, M. Exley, R.A. Schleipman, J. Glickman, D.T. Bailey, N. Corazza, S.P. Colgan, A.B. Onderdonk, and R.S. Blumberg CD1d - dependent macrophage - mediated clearance of Pseudomonas aeruginosa from lung Nat. Med. 8 2002 588 593
26. M.S. Duthie, M. Kahn, M. White, R.P. Kapur, and S.J. Kahn Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection Infect. Immun. 73 2005 1890 1894
27. D.R. Brown, D.J. Fowell, D.B. Corry, T.A. Wynn, N.H. Moskowitz, A.W. Cheever, R.M. Locksley, and S.L. Reiner Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses J. Exp. Med. 184 1996 1295 1304
28. S. Stenger, N. Donhauser, H. Thuring, M. Roellinghoff, and C. Bogdan Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase J. Exp. Med. 183 1996 1501 1514
29. A. Diefenbach, H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Roellinghoff, I. Gresser, and C. Bogdan Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite Immunity 8 1998 77 87
30. S. Stenger, H. Thuring, M. Roellinghoff, and C. Bogdan Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major J. Exp. Med. 180 1994 783 793
31. J. Mattner, H. Schindler, A. Diefenbach, M. Roellinghoff, I. Gresser, and C. Bogdan Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major Eur. J. Immunol. 30 2000 2257 2267
32. C. Bogdan Nitric oxide and the immune response Nat. Immunol. 2 2001 907 916
33. M. Skold, and S.M. Behar Role of CD1d-restricted NKT cells in microbial immunity Infect. Immun. 71 2003 5447 5455
34. T. Laskay, T.L. Miko, Y. Negesse, W. Solbach, M. Roellinghoff, and D. Frommel Early parasite containment is decisive for resistance to Leishmania major infection Eur. J. Immunol. 25 1995 2220 2227
35. H. Kitamura, K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. van Kaer, T. Kawano, M. Taniguchi, and T. Nishimura The Natural Killer T (NKT) cell ligand a-galactosylceramide demonstrates ist immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 Receptor expression on NKT cells J. Exp. Med. 189 1999 1121 1127
36. A. Diefenbach, H. Schindler, M. Roellinghoff, W.M. Yokoyama, and C. Bogdan Requirement for type 2 NO synthase for IL-12 signaling in innate immunity Science 284 1999 951 955
37. K.B. Nguyen, T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. durbin, and C.A. Biron Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection J. Immunol. 169 2002 4279 4287
38. J. Mattner, A. WanderseeSteinhauser, A. Pahl, M. Roellinghoff, G.R. Majeau, P.S. Hochman, and C. Bogdan Protection against progressive leishmaniasis by IFN-beta J. Immunol. 172 2004 7574 7582
39. S. Motohashi, S. Kobayashi, T. Ito, K.K. Magara, O. Mikuni, N. Kamada, T. Iizasa, T. Nakayama, T. Fujisawa, and M. Taniguchi Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients Int. J. Cancer 102 2002 159 165
40. S. Korten, R.J. Anderson, C.M. Hannan, E.G. Sheu, R. Sinden, S. Gadola, M. Taniguchi, and A.V. Hill Invariant Va14 chain NKT cells promote plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producting CD8+ T cells in the liver after poxvirus vaccination of mice Infect. Immun. 73 2005 849 858
41. Y. Kinjo, D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg Recognition of bacterial glycosphingolipids by natural killer T cells Nature 434 2005 520 525
42. K. Kawakami Critical role of Valpha 14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection Eur. J. Immunol. 33 2003 3322 3330
43. E.Y. Denkers, T. Scharton-Kersten, S. Barbieri, P. Caspar, and A. Sher A role for CD4+NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection J. Exp. Med. 184 1996 131 139
44. S.M. Behar, C.C. Dascher, M.J. Grusby, C.R. Wang, and M.B. Brenner Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis J. Exp. Med. 189 1999 1973 1980
45. J.F. Romero, G. Eberl, H.R. MacDonald, and G. Corradin CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice Parasite Immunol. 23 2001 267 269
46. K. Kawakami, Y. Kinjo, S. Yara, Y. Koguchi, K. Uezu, T. Nakayama, M. Taniguchi, and A. Saito Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans Infect. Immun. 69 2001 213 220
47. Y. Naiki, H. Nishimura, T. Kawano, Y. Tanaka, S. Itohara, M. Taniguchi, and Y. Yoshikai Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection J. Immunol. 163 1999 2057 2063
48. G. Szalay, C.H. Ladel, C. Blum, L. Brossay, M. Kronenberg, and S.H. Kaufmann Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice J. Immunol. 162 1999 6955 6958
49. K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac In vivo identification of glycolipid antigen specific T cells using fluorescent CD1d tetramers J. Exp. Med. 191 2000 1895 1903